Teleflex Incorporated (NYSE:TFX) Stock Holdings Lessened by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC reduced its stake in shares of Teleflex Incorporated (NYSE:TFX) by 4.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,301 shares of the medical technology company’s stock after selling 288 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Teleflex were worth $1,571,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Morgan Stanley boosted its stake in shares of Teleflex by 535.8% during the 4th quarter. Morgan Stanley now owns 2,691,192 shares of the medical technology company’s stock valued at $671,803,000 after buying an additional 2,267,889 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of Teleflex by 50.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 1,833,777 shares of the medical technology company’s stock worth $464,515,000 after acquiring an additional 612,019 shares in the last quarter. Norges Bank acquired a new stake in Teleflex during the fourth quarter valued at $104,344,000. LGT Capital Partners LTD. grew its stake in Teleflex by 285.4% in the fourth quarter. LGT Capital Partners LTD. now owns 257,864 shares of the medical technology company’s stock valued at $64,296,000 after purchasing an additional 190,950 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. increased its position in Teleflex by 2.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,633,473 shares of the medical technology company’s stock worth $2,155,174,000 after purchasing an additional 181,393 shares during the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Price Performance

Shares of Teleflex stock opened at $206.56 on Monday. The company has a current ratio of 2.32, a quick ratio of 1.29 and a debt-to-equity ratio of 0.39. The firm has a fifty day simple moving average of $225.49 and a 200-day simple moving average of $225.58. The stock has a market capitalization of $9.73 billion, a price-to-earnings ratio of 27.43, a PEG ratio of 1.98 and a beta of 1.11. Teleflex Incorporated has a 1-year low of $177.63 and a 1-year high of $276.43.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.26 by $0.12. The company had revenue of $773.90 million during the quarter, compared to analysts’ expectations of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same period in the prior year, the company earned $3.52 earnings per share. On average, sell-side analysts expect that Teleflex Incorporated will post 13.73 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date was Thursday, February 29th. Teleflex’s dividend payout ratio (DPR) is currently 18.06%.

Insiders Place Their Bets

In other news, VP Cameron P. Hicks sold 7,401 shares of the stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total value of $1,665,225.00. Following the completion of the sale, the vice president now directly owns 10,050 shares of the company’s stock, valued at $2,261,250. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.43% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Royal Bank of Canada reduced their price target on Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a report on Friday, February 23rd. JMP Securities reiterated a “market outperform” rating and issued a $285.00 target price on shares of Teleflex in a research note on Friday, February 23rd. StockNews.com lowered shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Finally, Truist Financial cut their price target on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a report on Friday, February 23rd. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $267.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.